The price of Mounjaro (tirzepatide) is influenced by multiple factors. Research and development (R&D) costs, including clinical trials and regulatory approval for its dual GIP/GLP-1 receptor agonist mechanism, contribute significantly .
Manufacturing expenses, such as recombinant DNA technology and sterile prefilled delivery systems (pens/vials), add to costs . As a branded drug with no generic alternatives, market exclusivity from patent protections allows premium pricing . Regulatory requirements for safety monitoring and specialized administration training (subcutaneous injection) also impact costs . Additionally, healthcare system variations (insurance coverage, regional pricing policies) affect patient out-of-pocket expenses. While its efficacy in glycemic control justifies value, these structural factors collectively drive its market price.

